Matches in Wikidata for { <http://www.wikidata.org/entity/Q73047747> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q73047747 description "article scientifique publié en 1997" @default.
- Q73047747 description "artikull shkencor i botuar më 01 shkurt 1997" @default.
- Q73047747 description "artículu científicu espublizáu en febreru de 1997" @default.
- Q73047747 description "im Februar 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73047747 description "scientific article published on 01 February 1997" @default.
- Q73047747 description "wetenschappelijk artikel" @default.
- Q73047747 description "наукова стаття, опублікована в лютому 1997" @default.
- Q73047747 description "գիտական հոդված հրատարակված 1997 թվականի փետրվարի 1-ին" @default.
- Q73047747 name "Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate" @default.
- Q73047747 name "Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate" @default.
- Q73047747 name "Differential effects of hormone-replacement therapy on endogenous nitric oxide" @default.
- Q73047747 type Item @default.
- Q73047747 label "Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate" @default.
- Q73047747 label "Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate" @default.
- Q73047747 label "Differential effects of hormone-replacement therapy on endogenous nitric oxide" @default.
- Q73047747 prefLabel "Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate" @default.
- Q73047747 prefLabel "Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate" @default.
- Q73047747 prefLabel "Differential effects of hormone-replacement therapy on endogenous nitric oxide" @default.
- Q73047747 P1433 Q73047747-65EA6155-7D03-4E15-86DF-D7C21D161085 @default.
- Q73047747 P1476 Q73047747-F41B2BBE-5DD2-4100-A201-8BA44F368C84 @default.
- Q73047747 P2093 Q73047747-0D959389-6A41-4116-97B5-F57E17F4D2F8 @default.
- Q73047747 P2093 Q73047747-5CA3158D-9FCB-4DE2-926B-E95EFB440BF9 @default.
- Q73047747 P2093 Q73047747-6DB7189E-72AE-47FD-86B3-F4EF17B9E4B1 @default.
- Q73047747 P2093 Q73047747-81779854-DE49-4B59-860D-1C70A755338D @default.
- Q73047747 P2093 Q73047747-88628987-9954-49AA-BAF6-9B0AC85381C3 @default.
- Q73047747 P304 Q73047747-CA175730-562B-46C8-A1A6-31282BE5E5B8 @default.
- Q73047747 P31 Q73047747-E8D60911-140F-4675-A4B7-D47B81EA232C @default.
- Q73047747 P356 Q73047747-0FC8B001-4ACD-4EC6-BEB4-1EE19627653E @default.
- Q73047747 P407 Q73047747-035CE88A-7609-4383-B2D7-319EB3E944E7 @default.
- Q73047747 P433 Q73047747-11058F37-8A49-4380-AB8A-41459C3E8A1B @default.
- Q73047747 P478 Q73047747-5BAF1C6F-795C-4E54-A39B-90238066CBE2 @default.
- Q73047747 P577 Q73047747-CCB6726C-3186-4CB6-BBBD-873242F4B859 @default.
- Q73047747 P698 Q73047747-06C0E672-4876-43BF-9B2B-6608531BD0EB @default.
- Q73047747 P921 Q73047747-A5890C01-CD22-4761-AE8B-B4D1F68AEF4D @default.
- Q73047747 P921 Q73047747-B7E1F8A1-B386-4C2B-9A46-4827FC3CA499 @default.
- Q73047747 P356 JCEM.82.2.3780 @default.
- Q73047747 P698 9024224 @default.
- Q73047747 P1433 Q3186902 @default.
- Q73047747 P1476 "Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate" @default.
- Q73047747 P2093 "Dubey RK" @default.
- Q73047747 P2093 "Imthurn B" @default.
- Q73047747 P2093 "Jaeger AW" @default.
- Q73047747 P2093 "Keller PJ" @default.
- Q73047747 P2093 "Rosselli M" @default.
- Q73047747 P304 "388-394" @default.
- Q73047747 P31 Q13442814 @default.
- Q73047747 P356 "10.1210/JCEM.82.2.3780" @default.
- Q73047747 P407 Q1860 @default.
- Q73047747 P433 "2" @default.
- Q73047747 P478 "82" @default.
- Q73047747 P577 "1997-02-01T00:00:00Z" @default.
- Q73047747 P698 "9024224" @default.
- Q73047747 P921 Q108667313 @default.
- Q73047747 P921 Q2823834 @default.